CLINICAL_TRIALS
trial_result
· 2014-04-11
Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children [Phase 1, Phase 2]
Summary
Phase 1/2 trial updates report safety, tolerability, and pharmacokinetic findings for efavirenz in HIV-infected children.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-04-11